Ischemic preconditioning prevents postischemic P-selectin expression in the rat small intestine
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, School of Medicine in Shreveport, Shreveport, Louisiana 71130 Ischemic preconditioning (IPC) prevents the deleterious effects of prolonged ischemia and reperfusion (I/R). Because leukocyte infiltratio...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 1999-12, Vol.277 (6), p.H2476-H2481 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Department of Molecular and Cellular Physiology, Louisiana State
University Health Sciences Center, School of Medicine in Shreveport,
Shreveport, Louisiana 71130
Ischemic preconditioning (IPC) prevents the
deleterious effects of prolonged ischemia and reperfusion
(I/R). Because leukocyte infiltration is required to produce the
microvascular dysfunction induced by I/R in the small intestine, and
P-selectin-dependent leukocyte rolling is a requisite step in this
process, we hypothesized that IPC would attenuate postischemic
P-selectin expression. To address this postulate, P-selectin expression
was evaluated in nonischemic (control) rat jejunum and in rat jejunum
subjected to I/R alone (20 min ischemia/60 min reperfusion), or
IPC (5 min ischemia/10 min reperfusion) + I/R using a dual
radiolabeled monoclonal antibody approach. I/R was associated with a
sevenfold increase in jejunal P-selectin expression, an effect that was
completely abolished by IPC. Exposing the bowel to adenosine deaminase
or an adenosine A 1 , but not an
A 2 , receptor antagonist during the period of preconditioning ischemia or to selective PKC
antagonists during prolonged ischemia prevented the beneficial
effect of IPC to limit I/R-induced P-selectin expression. Our data
indicate that P-selectin expression is a novel downstream effector
target of the adenosine-initiated, PKC-dependent, anti-inflammatory
signaling pathway in IPC.
ischemia; reperfusion; adenosine; protein kinase C; leukocyte rolling |
---|---|
ISSN: | 0363-6135 0002-9513 1522-1539 |
DOI: | 10.1152/ajpheart.1999.277.6.H2476 |